EIF2AK3 rs7571971: What Your Genotype Means
The rs7571971 variant is a single-nucleotide polymorphism located within the EIF2AK3 gene. Research has explored its potential role in modifying the risk of Alzheimer's disease, particularly in individuals who also carry the APOE-epsilon4 allele.
What each genotype means
Baseline risk profile
This genotype is considered the common or major allele in many populations. Research suggests that any potential influence of this variant on Alzheimer's disease risk is observed primarily in individuals who also carry the APOE-epsilon4 allele, rather than as an independent factor.
This is the most common genotype in many global populations, though frequencies vary significantly by ancestry.
Potential risk modifier
Carrying one copy of the T allele has been associated with modified Alzheimer's disease risk in some studies, specifically among individuals who are also APOE-epsilon4 carriers. This association is not independent of APOE status, and the clinical significance remains a subject of ongoing research.
This heterozygous genotype is found at varying frequencies across different ancestral groups, with the T allele having a reported minor allele frequency of approximately 0.25 to 0.28 in some studies.
Potential risk modifier
Carrying two copies of the T allele has been linked in some research to modified Alzheimer's disease risk, particularly in the presence of the APOE-epsilon4 allele. Because this effect is not independent of APOE, it is important to interpret this result in the context of your broader genetic profile and discuss any concerns with a healthcare professional.
This homozygous genotype is less common than the CC or CT genotypes in most populations, reflecting the lower frequency of the T allele.
Understanding the rs7571971 Variant
The rs7571971 variant is a specific genetic change, or single-nucleotide polymorphism (SNP), located within the EIF2AK3 gene. This gene is situated on chromosome 2. In genetic research, SNPs are common variations where a single building block of DNA—a nucleotide—differs between individuals. While many SNPs have no observable effect on health, researchers study them to see if they correlate with specific traits or disease risks. The rs7571971 variant has been a subject of interest in neurodegenerative research because of its location in a gene critical to cellular stress responses. It is important to note that this variant is often studied in the context of larger genetic patterns, such as haplotypes, rather than acting in isolation. Scientists use these markers to better understand the complex genetic architecture that may contribute to brain health and the development of conditions like Alzheimer's disease.
The Role of the EIF2AK3 Gene
The EIF2AK3 gene provides instructions for producing a protein called PERK (protein kinase R-like endoplasmic reticulum kinase). PERK is a vital component of the unfolded protein response (UPR), a cellular mechanism that helps manage stress within the endoplasmic reticulum, the part of the cell responsible for folding proteins. When proteins are misfolded, the UPR is activated to restore balance and prevent cellular damage. In the brain, this pathway is essential for maintaining proteostasis, or the healthy regulation of proteins. Research suggests that when PERK signaling is impaired or altered, it may contribute to the accumulation of misfolded proteins, such as tau, which are hallmarks of various neurodegenerative diseases. By studying variants in EIF2AK3, scientists aim to determine how changes in this protein's function might influence the brain's ability to handle stress and protect against neurodegeneration.
Research and Evidence Strength
The evidence linking rs7571971 to Alzheimer's disease is considered moderate and context-dependent. Early exploratory studies suggested that this variant might influence Alzheimer's risk, but primarily in individuals who are already carriers of the APOE-epsilon4 allele, a well-known genetic risk factor for the disease. These findings indicate that the variant may not act independently but rather through an interaction with other genetic factors. Furthermore, the same gene has been strongly associated with progressive supranuclear palsy (PSP), another neurodegenerative condition. While some studies have observed these associations, results can vary across different populations and study designs. It is crucial to understand that these are statistical associations observed in large groups, not direct causes of disease. Current research continues to investigate whether these variants lead to functional changes in PERK activity and how those changes might contribute to the complex pathology of Alzheimer's disease.
Population Frequency
The frequency of the rs7571971 variant is variable and depends on ancestral background. Genetic databases, such as the 1000 Genomes Project, provide data on how common these alleles are across different global populations. In many studies, the minor allele of this SNP is found at frequencies that allow for statistical analysis, but it is not rare. Because frequency can differ significantly between groups of European, Asian, and African descent, researchers must account for ancestry when interpreting the potential impact of this variant. The variability in frequency highlights the importance of large-scale, diverse genomic studies to confirm whether the associations observed in one cohort hold true across broader, more diverse populations.
Interpreting Your Genetic Information
If you have information about your rs7571971 genotype, it is important to view it within the context of current scientific understanding. This variant is a research-level marker, not a diagnostic tool. Having a specific genotype does not mean you will develop Alzheimer's disease, nor does it guarantee protection. Genetic risk is highly complex, involving many genes, environmental factors, and lifestyle choices. You cannot use this information to predict your personal health outcomes or to make medical decisions. If you are concerned about your risk for Alzheimer's disease or other neurodegenerative conditions, the most effective approach is to consult with a healthcare professional or a genetic counselor. They can help you understand your overall risk profile based on your family history and clinical symptoms, rather than focusing on a single genetic variant.
How common is this variant?
The frequency of the rs7571971 variant is variable across different ancestral populations, with minor allele frequencies typically ranging between 15% and 30%.
Frequently asked questions
Does having the rs7571971 variant mean I will get Alzheimer's?
No. This variant is only associated with a statistical change in risk in specific contexts, such as in APOE-epsilon4 carriers. It is not a diagnostic test and cannot predict whether an individual will develop Alzheimer's disease.
What is the relationship between EIF2AK3 and PERK?
EIF2AK3 is the gene that provides the instructions for the body to create the PERK protein. PERK is a key enzyme involved in the cell's stress response system.
Can I change my risk associated with this SNP?
Genetic variants are fixed at birth. However, Alzheimer's risk is influenced by many factors, including lifestyle, diet, and cardiovascular health, which are areas where individuals can often take proactive steps.
Should I get tested for this variant?
Clinical testing for this specific SNP is not standard practice for Alzheimer's risk assessment. If you have concerns about your cognitive health, you should speak with a neurologist or a primary care physician.
Sources & further reading
Educational information only, last refreshed 10/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7571971?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29